Mind Medicine (MindMed) MNMD Stock
Mind Medicine (MindMed) Price Chart
Mind Medicine (MindMed) MNMD Financial and Trading Overview
| Mind Medicine (MindMed) stock price | 5.43 USD |
| Previous Close | 3.62 USD |
| Open | 3.6 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 3.56 - 3.72 USD |
| 52 Week Range | 2.12 - 19.95 USD |
| Volume | 190.65K USD |
| Avg. Volume | 389.9K USD |
| Market Cap | 147.08M USD |
| Beta (5Y Monthly) | 2.161723 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.54 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.63 USD |
MNMD Valuation Measures
| Enterprise Value | 10.38M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0163043 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.0898943 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.151 |
Trading Information
Mind Medicine (MindMed) Stock Price History
| Beta (5Y Monthly) | 2.161723 |
| 52-Week Change | -65.065% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.95 USD |
| 52 Week Low | 2.12 USD |
| 50-Day Moving Average | 3.46 USD |
| 200-Day Moving Average | 3.68 USD |
MNMD Share Statistics
| Avg. Volume (3 month) | 389.9K USD |
| Avg. Daily Volume (10-Days) | 296.12K USD |
| Shares Outstanding | 38.6M |
| Float | 32.71M |
| Short Ratio | 8.78 |
| % Held by Insiders | 14.72% |
| % Held by Institutions | 13.62% |
| Shares Short | 2.83M |
| Short % of Float | 7.40% |
| Short % of Shares Outstanding | 7.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.17% |
| Return on Equity (ttm) | -47.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -68661000 USD |
| Net Income Avi to Common (ttm) | -63160000 USD |
| Diluted EPS (ttm) | -1.78 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 129.41M USD |
| Total Cash Per Share (mrq) | 3.35 USD |
| Total Debt (mrq) | 72K USD |
| Total Debt/Equity (mrq) | 0.06 USD |
| Current Ratio (mrq) | 5.495 |
| Book Value Per Share (mrq) | 3.404 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -50604000 USD |
| Levered Free Cash Flow (ttm) | -12858000 USD |
Profile of Mind Medicine (MindMed)
| Country | United States |
| State | NY |
| City | New York |
| Address | One World Trade Center |
| ZIP | 10007 |
| Phone | 650 208 2454 |
| Website | https://www.mindmed.co |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 48 |
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.
Q&A For Mind Medicine (MindMed) Stock
What is a current MNMD stock price?
Mind Medicine (MindMed) MNMD stock price today per share is 5.43 USD.
How to purchase Mind Medicine (MindMed) stock?
You can buy MNMD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mind Medicine (MindMed)?
The stock symbol or ticker of Mind Medicine (MindMed) is MNMD.
Which industry does the Mind Medicine (MindMed) company belong to?
The Mind Medicine (MindMed) industry is Biotechnology.
How many shares does Mind Medicine (MindMed) have in circulation?
The max supply of Mind Medicine (MindMed) shares is 75.37M.
What is Mind Medicine (MindMed) Price to Earnings Ratio (PE Ratio)?
Mind Medicine (MindMed) PE Ratio is now.
What was Mind Medicine (MindMed) earnings per share over the trailing 12 months (TTM)?
Mind Medicine (MindMed) EPS is -1.54 USD over the trailing 12 months.
Which sector does the Mind Medicine (MindMed) company belong to?
The Mind Medicine (MindMed) sector is Healthcare.
Mind Medicine (MindMed) MNMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}